Q2 EPS Forecast for Viking Therapeutics Reduced by Analyst
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – William Blair cut their Q2 2025 earnings per share estimates for shares of Viking Therapeutics in a report issued on Wednesday, April 23rd. William Blair analyst A. Hsieh now forecasts that the biotechnology company will post earnings of ($0.45) per share for the quarter, down from their […]
